What Sets the Field Apart
Living and complex products vary more than conventional drugs. Sourcing of cells and materials, manufacturing processes, and assays that show each batch works become part of the product itself and of its regulatory case.
Early Priorities
A mechanism supported by data in relevant models; a manufacturing approach that can grow beyond the academic lab; potency and characterization assays; intellectual property that covers methods as well as compositions; and a realistic view of cost of goods and delivery.
How We Help
We work with founders to plan the research that answers these questions, select partner labs suited to the methods, and connect the work to regulatory and financing milestones.
